The bioresorbable polymers market has experienced remarkable growth in recent years, thanks to the progress in medical technology, the rising demand for biocompatible materials, and the increasing emphasis on sustainable and environmentally friendly solutions. In 2021, the bioresorbable polymers market was valued at US$ 1.3 Billion, and it is expected to reach US$ 6.2 Billion by 2032, with a strong Compound Annual Growth Rate (CAGR) of 15.8% over the forecast period from 2022 to 2032. Bioresorbable polymers, also known as biodegradable or absorbable polymers, are materials that can be naturally broken down and absorbed by the body over time. These polymers have found diverse applications, particularly in the medical and pharmaceutical sectors.
Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7974
Market Dynamics:
The growth of the bioresorbable polymers market can be attributed to several factors. One primary driver is the increasing demand for biocompatible materials in medical applications. These polymers find extensive use in drug delivery systems, orthopedic implants, and tissue engineering, among other areas. The rising prevalence of chronic diseases has fueled the demand for advanced and patient-friendly treatment options, driving the adoption of bioresorbable polymers.
Additionally, stringent regulatory standards promoting the use of biodegradable materials and the growing awareness of environmental sustainability have further boosted the market. Bioresorbable polymers offer a sustainable solution, as they reduce the environmental impact associated with traditional medical devices.
Market Future Outlook:
The future outlook for the bioresorbable polymers market appears promising, with a projected steady growth trajectory. Advancements in polymer science and technology are expected to enhance the properties and functionalities of these polymers, expanding their applicability in various medical fields. Researchers are exploring novel formulations and processing techniques to optimize the mechanical and degradation characteristics of bioresorbable polymers, opening doors to new possibilities in regenerative medicine and beyond.
The market is likely to witness increased investment in research and development, driving innovation and the introduction of advanced bioresorbable polymer products. As the understanding of biocompatibility and degradation kinetics improves, the range of applications for these polymers is expected to diversify, encompassing areas such as cardiovascular devices, wound care, and neurosurgical applications.
Market Insights:
In-depth market insights reveal a growing preference for bioresorbable polymers over traditional materials in medical device manufacturing. The ability of these polymers to minimize inflammation and foreign body reactions while promoting tissue regeneration has positioned them as a favorable choice for medical professionals. Market studies indicate a rising adoption of bioresorbable polymers in drug-eluting stents, sutures, and other implantable medical devices.
Furthermore, collaborations between research institutions, pharmaceutical companies, and polymer manufacturers are fostering a collaborative ecosystem, driving advancements in bioresorbable polymer technology. The sharing of knowledge and resources is expected to accelerate the development and commercialization of new products, thereby positively impacting market growth.
Key Players:
- Corbion N V
- Evonik Industries AG
- Poly-Med, Inc.
- KLS Martin Group
- Foster Corporation
- Ashland Global Holdings Inc.
- DSM Biomedical, Inc
- Zeus Industrial Products, Inc
- REVA Medical, LLC.
- Poly-Med Incorporated
- Bezwada Biomedical
- Nomisma Healthcare Pvt. Ltd.
Competitive Landscape:
In March 2021, Ashland Global Holdings Inc. undertook an expansion of its production plant for Viatel bioresorbable polymer and relocated its research and development (R&D) activities from Dublin to the National Science Park in Mullingar.
In September 2020, Corbion and Total jointly announced their intentions to establish a state-of-the-art polylactic acid bioplastics plant in Europe. This facility, which will be the first of its kind on a global scale in Europe, is projected to have a production capacity of 100 thousand tonnes per year. The new plant is scheduled to commence operations in 2024 and will be situated in France. This strategic investment in polylactic acid will expedite plans to augment lactic acid production and effectively address the growing demand for polymers.
Market Segmentation
- By Product Type :
- Biopolyesters
- Agro-polymers
- By Application :
- Orthopedics
- Drug Delivery
- Other Applications
- By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=7974
About Fact.MR :
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400 Rockville, MD 20852
United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: [email protected]
